FcγRIIA polymorphisms in Streptococcus pneumoniae infection

Immunology and Cell Biology

Volumn 81, Issue 3, 2003, Pages 192-195

  Yuan, Fang Fang ^a,c   Wong, Melanie ^b   Pererva, Natalia ^a   Keating, Joanna ^a   Davis, Andrew R ^a   Bryant, Jenny A ^a   Sullivan, John S ^a  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c Tissue Typing Laboratory   (Australia)

Author keywords

Fc RIIA; Genotype; Pneumococcal sepsis

Indexed keywords

FC GAMMA RECEPTOR 2A; FC GAMMA RECEPTOR 2A H131; FC GAMMA RECEPTOR 2A R131; FC RECEPTOR; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN RECEPTOR; UNCLASSIFIED DRUG; FC GAMMA RECEPTOR IIA; LEUKOCYTE ANTIGEN;

ARTICLE; CELL INVASION; CELL PROTECTION; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DISEASE COURSE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; INCIDENCE; INFANT; INFECTION CONTROL; INFECTION RISK; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; PHAGOCYTOSIS; POPULATION DISTRIBUTION; RANDOMIZATION; RECEPTOR BINDING; SEPSIS; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; GENETICS; IMMUNOLOGY; NEWBORN; PRESCHOOL CHILD; RISK FACTOR;

POSIBACTERIA; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

ANTIGENS, CD; CHILD; CHILD, PRESCHOOL; GENE FREQUENCY; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; PNEUMOCOCCAL INFECTIONS; POLYMORPHISM, GENETIC; RECEPTORS, IGG; RISK FACTORS; STREPTOCOCCUS PNEUMONIAE;

EID: 0038356320     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.2003.01158.x     Document Type: Article

References (19)

1. Jefferis R, Kumarartne DS. Selective IgG subclass deficiency: quantification and clinical relevance. Clin. Exp. Immunol. 1990; 81: 357-67.
2. Siber GR, Schur PH, Aisenberg AC, Weitzman SA, Schiffman G. Correlation between serum IgG2 concentrations and the antibody response to bacterial polysaccharide antigens. N. Engt. J. Med. 1980; 303: 178-82.
3. Sanders LAM, Feldman RG, Voorhorst-Ogink MM et al. Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils. Infect. Immun. 1995; 63: 73-81.
4. Rodriguez ME, van der Pol WL, Sanders LAM, van de Winkel JGJ. Crucial role of FcγRIIa (CD32) in assessment of functional anti-Streptococcus pneumoniae antibody activity in human sera. J. Infect. Dis. 1999; 179: 423-33.
5. Jansen WTM, Breukels MA, Snippe H, Sanders LAM, Verheul AFM, Rijkers GT. Fcγ receptor polymorphisms determine the magnitude of in vitro phagocytosis of Streptococcus pneumoniae mediated by pneumococcal conjugate sera. J. Infect. Dis. 1999; 180: 888-91.
6. Abadi J, Zhong Z, Dobroszyzki J, Pirofski LA. FcγRIIa polymorphism in human immunodeficiency virus-infected children with invasive pneumococcal disease. Pediatr. Res. 1997; 42: 259-62.
7. Bunce M, O'Neill CM, Barnardo MC et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995; 46: 355-67.
8. Yee AMF, Phan HM, Zuniga R, Salmon JE, Musher DM. Association between FcγRIIa-R131 allotype and bacteremic pneumococcal pneumonia. Clin. Infect. Dis. 2000; 30: 25-8.
9. Platonov AE, Shipulin GA, Vershinina IV, Dankert J, van de Winkel JGJ, Kuijper EJ. Association of human FcγRIIa (CD32) polymorphism with susceptibility to and severity of meningococcal disease. Clin. Infect. Dis. 1998; 27: 746-50.
10. Bredius RGM, Derkx BHF, Fijen CAP et al. Fcγ receptor IIa (CD32) polymorphism in Fulminant meningococcal septic shock in children. J. Infect. Dis. 1994; 170: 848-53.
11. Domingo P, Muniz-Diaz E, Baraldes MA et al. Associations between Fc gamma receptor IIA polymorphisms and the risk and prognosis of meningococcal disease. Am. J. Med. 2002; 112: 19-25.
12. Sanders LAM, van de Winkel JG, Rijkers GT et al. Fcγ receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections. J. Infect. Dis. 1994; 170: 854-61.
13. H3 gene segment usage. J. Infect. Dis. 1998; 178: 707-16.
14. Norris CF, Surrey S, Bunin GR, Schwartz E, Buchanan GR, McKenzie SE. Relationship between Fc receptor IIA polymorphism and infection in children with sickle cell disease. J. Pediatr. 1996; 128: 813-9.
15. Konradsen HB, Oxelius V-A, Hahn-Zoric M, Hanson LA. The importance of G1m and 2 allotypes for the IgG2 antibody levels and avidity against pneumococcal polysaccharide type 1 within mono- and dizygotic twin-pairs. Scand. J. Immunol. 1994; 40: 251-6.
16. Parren PW, Warmerdam PA, Boeije LC et al. On the interaction of IgG subclasses with the low affinity FcγRIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2. J. Clin. Invest. 1992; 90: 1537-46.
17. Johnson SE, Rubin L, Romero-Steiner S et al. Correlation of opsonophagocytosis and passive protection assays using human anticapsular antibodies in an infant mouse model of bacteremia for Streptococcus pneumoniae. J. Infect. Dis. 1999; 180: 133-40.
18. Vernacchio L, Romero-Steiner S, Martinez JE et al. Comparison of an opsonophagocytic assay and IgG ELISA to assess responses to pneumococcal polysaccharide and pneumococcal conjugate vaccines in children and young with sickle cell disease. J. Infect. Dis. 2000; 181: 1162-6.
19. Van der Pol WL, van de Winkel JGJ. IgG receptor polymorphisms: risk factor for disease. Immunogenetics 1998; 48: 222-32.